Your session is about to expire
← Back to Search
Ultrasound-Guided Tunneling for Bacterial Blood Infection (UGIST Trial)
N/A
Waitlist Available
Led By Salah A Taqi, MBChB
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult ICU patients.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-8 weeks for all 20 pts.
Awards & highlights
UGIST Trial Summary
This trial will compare the incidence of central line infections for those who have their lines tunneled with ultrasound guidance versus those who have their lines tunneled without ultrasound guidance.
Who is the study for?
This trial is for adult ICU patients who need a standard central venous catheter in place for at least 48 hours. It's not suitable for those with certain heart valve issues, no access to ultrasound, special line requirements like dialysis, neck protection due to injury, tumors reaching the heart, bleeding disorders, existing lines or infections in the area, new pacemaker leads or recent carotid surgery.Check my eligibility
What is being tested?
The UGIST study is testing whether tunneling short-term central venous catheters under the skin using ultrasound guidance can reduce infection risk compared to not tunneling them. The procedure involves placing these catheters into the neck vein and seeing if this method makes placement safer and easier.See study design
What are the potential side effects?
Potential side effects may include discomfort at the insertion site, bruising or bleeding due to needle puncture, infection risks from introducing a foreign body internally and possible complications related to incorrect catheter placement.
UGIST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult currently in intensive care.
UGIST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-8 weeks for all 20 pts.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-8 weeks for all 20 pts.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in Technical difficulty
Secondary outcome measures
Signs of line related blood stream infection/bacteremia.
UGIST Trial Design
2Treatment groups
Active Control
Group I: 2Active Control1 Intervention
Not to tunnel
Group II: 1Active Control1 Intervention
To Tunnel
Find a Location
Who is running the clinical trial?
Hamilton Health Sciences CorporationLead Sponsor
368 Previous Clinical Trials
300,973 Total Patients Enrolled
7 Trials studying Infections
27,022 Patients Enrolled for Infections
Salah A Taqi, MBChBPrincipal InvestigatorMcMaster Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult currently in intensive care.I have a long-term blood clotting disorder.I have an infection or mass on my skin.I need special medical lines, like for dialysis.I have growths on my heart's tricuspid valve.I recently had surgery to clear a blocked artery in my neck on one side.My tumor has grown into the right side of my heart.
Research Study Groups:
This trial has the following groups:- Group 1: 2
- Group 2: 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this research effort still available?
"According to clinicaltrials.gov, this medical experiment is not presently seeking patients. Originally published on March 1st 2008, the listing was last updated April 10th of that same year. Despite being inactive at present, 66 other trials are actively enrolling volunteers for their research studies."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger